Discuss This Disease

4 free views remaining today

neuronal intestinal dysplasia type A

Description

Neuronal Intestinal Dysplasia Type A (IND-A)

Neuronal intestinal dysplasia type A, also known as IND-A, is a rare congenital disorder that affects the development of the enteric nervous system in the intestine. It is characterized by an abnormal proliferation of nerve cells and fibers in the submucosal plexus of the intestine.

Key Features:

  • Congenital aplasia or hypoplasia: IND-A is often associated with congenital aplasia or hypoplasia of the sympathetic innervation, which can lead to a range of gastrointestinal symptoms.
  • Neonatal presentation: The condition typically presents in the neonatal period, with symptoms such as intestinal obstruction, diarrhea, and bloody stools.
  • Type A vs. Type B: IND-A is distinct from type B, which has a different clinical presentation and may be associated with other neuropathies.

Clinical Implications:

  • Bowel obstruction: IND-A can cause bowel obstruction due to the abnormal proliferation of nerve cells and fibers in the intestine.
  • Diarrhea and bloody stools: The condition is often characterized by episodes of diarrhea and bloody stools, which can be severe and life-threatening if left untreated.

References:

  • [1] Fadda and associates (1983) described IND-A as a congenital disorder affecting the enteric nervous system.
  • [2] March 3, 2023 - Intestinal neuronal dysplasia (IND) is an inherited disease of the intestine that affects one in 3000 children and adults, with type A being a distinct entity.

Additional Characteristics

  • Neuronal intestinal dysplasia type A (IND-A)
  • a rare congenital disorder
  • characterized by an abnormal proliferation of nerve cells and fibers in the submucosal plexus of the intestine
  • typically presents in the neonatal period with symptoms such as intestinal obstruction, diarrhea, and bloody stools
  • can cause bowel obstruction due to the abnormal proliferation of nerve cells and fibers in the intestine
  • often characterized by episodes of diarrhea and bloody stools

Signs and Symptoms

Severe Constipation and Enterocolitis in Neonatal Period

Neuronal intestinal dysplasia (IND) type A is characterized by severe constipation and enterocolitis, which typically manifest in the neonatal period. This condition can lead to significant morbidity if left untreated.

  • Severe Constipation: One of the hallmark symptoms of IND-A is severe constipation, which can be accompanied by abdominal distension (1).
  • Enterocolitis: Enterocolitis, an inflammation of the intestines, is another common symptom associated with IND-A (1).

These symptoms can be quite distressing for both the child and their caregivers. It's essential to seek medical attention if you suspect your child may have IND-A.

References: [1] - Context result 1: "IND type A usually manifests acutely in the neonatal period as severe constipation and enterocolitis."

Additional Symptoms

  • Enterocolitis
  • Severe Constipation

Diagnostic Tests

Neuronal intestinal dysplasia (NID) type A is a rare condition that can mimic Hirschsprung's disease, and its diagnosis poses a significant challenge to clinicians and pathologists alike.

Diagnostic tests for NID type A:

  • Rectal biopsy: This is the gold standard diagnostic test for NID type A. The biopsy should be performed on rectal tissue and examined using histopathological analysis.
  • Acetylcholinesterase (AChE) activity staining: This test can help identify the presence of abnormal ganglia in the submucosal plexus, which is a characteristic feature of NID type A.
  • Lactate or succinate dehydrogenase (LDH/SDH) staining: These tests can also be used to identify abnormal ganglia and confirm the diagnosis of NID type A.

Other diagnostic methods:

  • Barium enema: This test can help rule out other causes of bowel obstruction, such as Hirschsprung's disease.
  • Anorectal manometry: This test can provide information on the function of the anorectal region and may be helpful in diagnosing NID type A.

Important considerations:

  • The diagnosis of NID type A should only be made if there is a clear histopathological evidence of abnormal ganglia and neural hypertrophy.
  • Controversy exists over the diagnostic criteria for NID type A, and further research is needed to establish a consensus on this issue.

References:

[1] Meier-Ruge, WA ∙ Brönnimann, D. (1971). Intestinal neuronal dysplasia of the submucous plexus in infants and children. Virchows Archiv A Pathologische Anatomie und Physiologie Klinische Diagnostik, 420(2), 171-176.

[13] Neuronal intestinal dysplasia (NID) is an inhibitory malformation of the submucous and myenteric plexuses. The diagnosis is made by examination of mucosal biopsies after histotopochemical reactions for acetylcholinesterase and lactate or succinate dehydrogenase.

[14] INTESTINAL NEURONAL DYSPLASIA (IND), a clinical condition that resembles Hirschsprung’s disease (HD), was first described by Meier-Ruge in 1971 as a malformation of the enteric plexus.

Additional Diagnostic Tests

  • Barium enema
  • Rectal biopsy
  • Anorectal manometry
  • Acetylcholinesterase (AChE) activity staining
  • SDH) staining

Treatment

Based on the provided context, it appears that there is limited information available on the specific treatment for intestinal neuronal dysplasia type A (IND-A). However, I can provide some general information on the topic.

Intestinal neuronal dysplasia (IND) is a rare condition characterized by abnormal nerve cells in the intestine. There are two types of IND: type A and type B. Type A is typically associated with more severe symptoms and a poorer prognosis compared to type B.

Regarding treatment, it seems that there is no specific mention of drug treatment for IND-A in the provided context. However, I can provide some general information on the treatment options for IND.

  • Conservative medical therapy: This may include changes in diet, laxatives, or other measures to manage symptoms (see [6] and [10]).
  • Surgical treatment: This may be considered in severe cases or when conservative management is unsuccessful (see [3], [4], and [5]).

It's worth noting that the provided context does not specifically mention drug treatment for IND-A. However, it's possible that some of the treatments mentioned above may involve medication as part of a comprehensive treatment plan.

If you're looking for more specific information on drug treatment for IND-A, I would recommend searching for more recent or specialized sources.

Recommended Medications

  • Surgical treatment
  • Conservative medical therapy

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

Differential Diagnosis of Neuronal Intestinal Dysplasia Type A

Neuronal intestinal dysplasia (NID) type A is a rare condition that affects the intestinal nerve plexuses. In order to accurately diagnose NID-A, it's essential to consider its differential diagnosis.

  • Hirschsprung's disease: This is an uncommon disease caused by a failure of migration of neural crest cells, leading to a congenital aganglionic megacolon. Hirschsprung's disease can mimic the symptoms of NID-A, making differential diagnosis crucial [9][10].
  • Other small bowel obstructions: The ultrasonographic diagnosis of type A intestinal neuronal dysplasia may also show diverse features like other small bowel obstruction [5][8].

Key differences between NID-A and Hirschsprung's disease:

  • NID-A is characterized by congenital aplasia or hypoplasia of the sympathetic innervation, whereas Hirschsprung's disease involves a failure of migration of neural crest cells.
  • The symptoms of NID-A may vary from acute intestinal obstruction to diarrhea with hemorrhagic stools, while Hirschsprung's disease typically presents with constipation and abdominal distension.

Importance of accurate diagnosis:

Accurate differential diagnosis is crucial in order to provide the appropriate treatment for patients with NID-A. Untreated cases, particularly of type A, may prove fatal [11][12][13].

References:

[9] CJ Berg · 2016 · Cited by 3 — Hirschsprung's disease (HD), also known as congenital aganglionic megacolon, is an uncommon disease caused by a failure of migration of neural crest cells ...

[10] Also known as neuronal colonic dysplasia, hyperganglionosis, pseudo or variant Hirschsprung’s disease; has disturbed submucous plexus development (Semin Pediatr Surg 2009;18:206)

[11] Intestinal neuronal dysplasia is a rare cause of bowel obstruction in neonates and infants, the diagnosis of which poses a formidable challenge to both clinicians and pathologists alike.

[12] Intestinal neuronal dysplasia is a rare cause of bowel obstruction in neonates and infants, the diagnosis of which poses a formidable challenge to both clinicians and pathologists alike. The importance of this entity lies not only in the fact that it mimics Hirschsprung’s disease, but also in that untreated cases, particularly of type A, may prove fatal.

[13] Intestinal neuronal dysplasia is a rare cause of bowel obstruction in neonates and infants, the diagnosis of which poses a formidable challenge to both clinicians and pathologists alike. The importance of this entity lies not only in the fact that it mimics Hirschsprung’s disease, but also in that untreated cases, particularly of type A, may prove fatal.

Additional Information

oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#id
DOID:0080679
core#notation
DOID:0080679
oboInOwl#hasDbXref
MIM:243180
IAO_0000115
An intestinal pseudo-obstruction that is characterized by congenital hypoplasia or aplasia of the sympathetic innervation of the intestine.
rdf-schema#label
neuronal intestinal dysplasia type A
rdf-schema#subClassOf
http://purl.obolibrary.org/obo/DOID_0080072
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_3539
owl#annotatedSource
t357793

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.